FEDERATED HERMES, INC. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$845
+0.6%
1700.0%0.00%
Q1 2023$840
-100.0%
170
-99.9%
0.00%
-100.0%
Q4 2022$1,722,535
+172153.5%
273,853
+636767.4%
0.01%
Q3 2022$1,0000.0%430.0%0.00%
Q2 2022$1,000
-99.8%
43
-99.9%
0.00%
-100.0%
Q1 2022$535,000
+32.1%
58,693
+265.8%
0.00%0.0%
Q4 2020$405,000
-87.2%
16,044
-80.9%
0.00%
-85.7%
Q3 2020$3,171,000
-37.1%
84,088
-28.6%
0.01%
-41.7%
Q2 2020$5,040,000
-0.4%
117,707
-32.7%
0.01%
-7.7%
Q1 2019$5,059,000
+7.3%
175,0000.0%0.01%0.0%
Q4 2018$4,713,000175,0000.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders